{Reference Type}: Case Reports
{Title}: Case report of possible iatrogenic Cushing's disease with low-dose prednisone to treat dermal filler hypersensitivity.
{Author}: Grillo R;
{Journal}: J Cosmet Dermatol
{Volume}: 21
{Issue}: 12
{Year}: Dec 2022
{Factor}: 2.189
{DOI}: 10.1111/jocd.15391
{Abstract}: <B>OBJECTIVE: </B>The aim of this article is to report a case of iatrogenic Cushing's disease associated with a delayed inflammatory response due to a facial dermal filler procedure.<BR><B>METHODS: </B>A case report according to CARE guidelines was performed. A delayed inflammatory reaction due to dermal filler injection resulted in iatrogenic Cushing's disease in a patient with no comorbidities or allergies.<BR><B>RESULTS: </B>Prolonged use of glucocorticoids can cause adverse effects, such as iatrogenic Cushing's disease. Dermal fillers have a very low incidence of complications, but these need to be discussed with patients. Drugs used to treat delayed inflammatory reaction include antibiotics, antihistamines, steroids, and intralesional hyaluronidase. Reversal of dermal fillers should be explained to the patient and included in the written consent.<BR><B>CONCLUSIONS: </B>Due to patient non-compliance and possible adverse effects of steroid medications, physicians should consider limiting their prescriptions of steroid medications to no more than 2 weeks and require frequent follow-up to discuss hyaluronidase if the condition returns off of steroid medication. In addition, it may be advisable to only treat with one filler brand, especially in the same session as this may be a risk factor.